- Surgical Perspectives of Hepatocellular Carcinoma beyond the Barcelona Clinical Liver Cancer Guideline; Focusing on Liver Resection
-
Kim DS
- KMID: 2154067
- J Liver Cancer.
- 2015 Mar;15(1):1-3.
- doi: 10.0000/jlc.2015.15.1.1
Although surgical resection can provide best treatment outcome with curative intent, patients with relatively early stage of hepatocellular carcinoma (HCC) can get benefit of this treatment. Barcelona Clinic Liver Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Perspectives of Hepatocellular Carcinoma beyond the Barcelona Clinical Liver Cancer Guideline; Focusing on Liver Transplantation
-
Yi NJ, Lee KW, Suh KS
- KMID: 2154068
- J Liver Cancer.
- 2015 Mar;15(1):4-10.
- doi: 10.0000/jlc.2015.15.1.4
The management of hepatocellular carcinoma (HCC) is decided according to the evidence base recommendations generated by international societies especially by Barcelona clinical liver cancer (BCLC) guideline. However, the BCLC guideline... -
- CITED
-
- Close
- SHARE
-
- Close
- 3 Cases of Portal Vein Thrombosis in Hepatocellular Carcinoma and Liver Cirrhosis Treated with Anticoagulation
-
Ahn BM, Lee ES, Kim SH, Lee BS, Lee HY
- KMID: 2154076
- J Liver Cancer.
- 2015 Mar;15(1):57-63.
- doi: 10.0000/jlc.2015.15.1.57
The reported prevalence of PVT is in the range of 0.6-15.8% in patient with liver cirrhosis or portal hypertension. If the patient has hepatocellular carcinoma, thrombus is likely to be... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Extrahepatic Metastasis of Hepatocellular Carcinoma to the Pronator Quadratus Muscle of Right Wrist
-
Song YW, Lee BS, Kim SH, Lee ES, Lee HY
- KMID: 2154073
- J Liver Cancer.
- 2015 Mar;15(1):41-45.
- doi: 10.0000/jlc.2015.15.1.41
Hepatocellular carcinoma (HCC) is usually associated with chronic liver disease such as liver cirrhosis. Primary HCC lesions and even recurrent intrahepatic lesions can be treated successfully by using variable modalities... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis
-
Yang TY, Shin SP, Lee JH, Lee YB, Park H, Hwang SG, Rim KS
- KMID: 2154075
- J Liver Cancer.
- 2015 Mar;15(1):52-56.
- doi: 10.0000/jlc.2015.15.1.52
Patients with advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) have an extremely poor prognosis. Although the Barcelona Clinic Liver Cancer guideline recommends sorafenib in advanced HCC with PVT,... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Yttrium-90 Radioembolization in the Management of Hepatocellular Carcinoma
-
Kim DY
- KMID: 2154069
- J Liver Cancer.
- 2015 Mar;15(1):11-18.
- doi: 10.0000/jlc.2015.15.1.11
Yttrium-90 radioembolization has emerged as a novel therapy for hepatocellular carcinoma (HCC) of intermediate or advanced stage. Yttrium-90 has characteristics of short half-life and tissue penetration depth. Potent anti-cancer effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Spontaneous Regression of Recurred Hepatocellular Carcinoma with Multiple Lung Metastases
-
Yoon BY, Lee HY, Hwang SW, Park SY, Kim HJ, Jang HW, Lee BS
- KMID: 2154074
- J Liver Cancer.
- 2015 Mar;15(1):46-51.
- doi: 10.0000/jlc.2015.15.1.46
Hepatocellular carcinoma (HCC) is the most common form of liver malignancy. Spontaneous regression of HCC is extremely rare phenomenon and mechanism of regression remains ob-scure. 75-year-old woman previously diagnosed with... -
- CITED
-
- Close
- SHARE
-
- Close
- Loss of Liver Fatty Acid Binding Protein Expression in Hepatocellular Carcinomas is Associated with a Decreased Recurrence-Free Survival
-
Kim H, Lee H, Park YN
- KMID: 2154071
- J Liver Cancer.
- 2015 Mar;15(1):30-35.
- doi: 10.0000/jlc.2015.15.1.30
BACKGROUND/AIMS: Loss of liver fatty acid binding protein (LFABP) expression by immunohis-tochemistry is a useful marker for the identification of hepatocyte nuclear factor 1alpha (HNF1alpha)-inactivated hepatocellular adenomas; however, the expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemangioma Diagnosed by Gadoxetate Disodium-Enhanced MRI in a Patient with Chronic Hepatitis C
-
Mo JW, Ryu SH, Park DW, Yoon WJ, Kim JN, Moon JS, Shim JC
- KMID: 2154072
- J Liver Cancer.
- 2015 Mar;15(1):36-40.
- doi: 10.0000/jlc.2015.15.1.36
A hemangioma is the most common benign hepatic tumor. Many hepatic hemangioma tend to be found incidentally, but should be differentiated from malignant tumors, especially in patients with a high... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Achieving Complete Remission with Combination of Stereotac-tic Body Radiation Therapy and Transarterial Chemoemoblization in Pa-tients with 4.8 cm Sized Infiltrative Hepatocellular Carcinoma with Arte-riovenous Shunt
-
Hwang SY, Lee SM, Im JW, Kim JS, Jeon KJ, Ahn SB, Ji EK, Kang HC, Choi CW, Yang GM
- KMID: 2154077
- J Liver Cancer.
- 2015 Mar;15(1):64-69.
- doi: 10.0000/jlc.2015.15.1.64
Infiltrative hepatocellular carcinoma (HCC) patients have a poor prognosis because most patients present with advanced disease. Although tumor size is small, ablation therapy is difficult because it is difficult to... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial Chemoembolization versus Radiofrequency Ablation for Small Hepatocellular Carcinomas with Discrepant Features on Computed Tomography and Magnetic Resonance Imaging
-
Cho YY, Kwon JH, Lee JH, Lee JM, Lee JY, Kim HC, Chung JW, Choi WM, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Kim CY, Lee HS
- KMID: 2154070
- J Liver Cancer.
- 2015 Mar;15(1):19-29.
- doi: 10.0000/jlc.2015.15.1.19
BACKGROUND/AIMS: This study compared the outcomes of patients with small hepatocellular carcinomas (HCCs) who were treated using transarterial chemoembolization (TACE) or radiofrequency ablation (RFA). METHODS: This was a post-hoc analysis of... -
- CITED
-
- Close
- SHARE
-
- Close
